Hanmi’s 4 products including ‘Amosartan 5/50mg’ manufactured worth of KRW 67.2 billion
The last year’s total manufactured amount of products which were approved as an incrementally modified drug was KRW 184.2 billion, and the Hanmi Pharm’s 4 products including ‘Amosartan 5/50mg’ were recorded at KRW 67.2 billion in the category.
According to the 2015 pharmaceutical manufacturing ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
